Cargando…
(13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans
We determined whether ring-2 carbon of histidine is folate-dependently transferred to carbons 8 (C(8)) and/or 2 (C(2)) in urinary uric acid in humans. Two adults collected each urine void for four days. Aliquots of urine for the first day were used for baseline values; then the subjects ingested 0.7...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303862/ https://www.ncbi.nlm.nih.gov/pubmed/25608940 http://dx.doi.org/10.3390/nu7010697 |
_version_ | 1782353988094525440 |
---|---|
author | Tamura, Tsunenobu Baggott, Joseph E. |
author_facet | Tamura, Tsunenobu Baggott, Joseph E. |
author_sort | Tamura, Tsunenobu |
collection | PubMed |
description | We determined whether ring-2 carbon of histidine is folate-dependently transferred to carbons 8 (C(8)) and/or 2 (C(2)) in urinary uric acid in humans. Two adults collected each urine void for four days. Aliquots of urine for the first day were used for baseline values; then the subjects ingested 0.7 g (3.3 mmol) of l-[ring-2-(13)C]histidine and collected urine for three experimental days. Aliquots were analyzed for percentage (13)C-content at C(2) and C(8) by a liquid-chromatography-mass spectrometry method. Percentage enrichment was determined by subtracting time-of-day paired baseline percentage (13)C-content from experimental percentage (13)C-content for each void. C(2) was predominantly (13)C-enriched in the majority of voids. The percentage enrichments at C(2) for two subjects were 0.14 (±0.028 [SEM], n = 26) and 0.18 (±0.049, n = 21), whereas at C(8), they were 0.008 (±0.006) and −0.005 (±0.008), respectively. The mean C(2)-enrichments were significantly greater than zero (p < 0.01), whereas those of C(8) were not (p > 0.2). The enrichment had a diurnal rhythm peaking in the morning. Our results may be useful in the estimation of the timing for the administration of drugs that interfere with purine nucleotide biosynthesis in the treatment of cancer and autoimmune disease. |
format | Online Article Text |
id | pubmed-4303862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-43038622015-02-02 (13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans Tamura, Tsunenobu Baggott, Joseph E. Nutrients Article We determined whether ring-2 carbon of histidine is folate-dependently transferred to carbons 8 (C(8)) and/or 2 (C(2)) in urinary uric acid in humans. Two adults collected each urine void for four days. Aliquots of urine for the first day were used for baseline values; then the subjects ingested 0.7 g (3.3 mmol) of l-[ring-2-(13)C]histidine and collected urine for three experimental days. Aliquots were analyzed for percentage (13)C-content at C(2) and C(8) by a liquid-chromatography-mass spectrometry method. Percentage enrichment was determined by subtracting time-of-day paired baseline percentage (13)C-content from experimental percentage (13)C-content for each void. C(2) was predominantly (13)C-enriched in the majority of voids. The percentage enrichments at C(2) for two subjects were 0.14 (±0.028 [SEM], n = 26) and 0.18 (±0.049, n = 21), whereas at C(8), they were 0.008 (±0.006) and −0.005 (±0.008), respectively. The mean C(2)-enrichments were significantly greater than zero (p < 0.01), whereas those of C(8) were not (p > 0.2). The enrichment had a diurnal rhythm peaking in the morning. Our results may be useful in the estimation of the timing for the administration of drugs that interfere with purine nucleotide biosynthesis in the treatment of cancer and autoimmune disease. MDPI 2015-01-20 /pmc/articles/PMC4303862/ /pubmed/25608940 http://dx.doi.org/10.3390/nu7010697 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tamura, Tsunenobu Baggott, Joseph E. (13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans |
title | (13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans |
title_full | (13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans |
title_fullStr | (13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans |
title_full_unstemmed | (13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans |
title_short | (13)C-Enrichment of Urinary Uric Acid after l-[Ring-2-(13)C]Histidine Dose in Adult Humans |
title_sort | (13)c-enrichment of urinary uric acid after l-[ring-2-(13)c]histidine dose in adult humans |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303862/ https://www.ncbi.nlm.nih.gov/pubmed/25608940 http://dx.doi.org/10.3390/nu7010697 |
work_keys_str_mv | AT tamuratsunenobu 13cenrichmentofurinaryuricacidafterlring213chistidinedoseinadulthumans AT baggottjosephe 13cenrichmentofurinaryuricacidafterlring213chistidinedoseinadulthumans |